Sunshine Biopharma (SBFM) Non Operating Income (2012 - 2026)
Sunshine Biopharma's Non Operating Income was $48,810 in Q2 2026, down 34.6% from $74,655 a year earlier and down 67.8% from the prior quarter.
Powered by 
Analysis
Sunshine Biopharma (SBFM) Non Operating Income (2012 - 2026) Analysis & Trends
On a trailing twelve-month basis, Sunshine Biopharma's Non Operating Income was $323,351 through Jun 30, 2026; for FY2025, it was $273,286, down 38.3% from FY2024.
- In earlier years, Non Operating Income was $443,147 in FY2024 (-34.3%), $674,421 in FY2023 (+37.7%), $489,614 in FY2022 and -$10 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly Non Operating Income since Q4 2024.
- Compared with a year earlier, Non Operating Income was higher in 1 of the last six quarters, with an average decline of 17.7%.
- The best year-over-year quarter for Non Operating Income over five years was Q2 2024 (growth of 115.7%); the worst was Q4 2022 (a decline of 91.1%).
- Per Business Quant data, SBFM's Non Operating Income in the three quarters before Q2 2026 was $151,728 (Q1 2026), $57,458 (Q4 2025) and $65,355 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Sunshine Biopharma | 1.05 Mn | -38.04 Mn | 2.43 Mn | 48,810.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 48,810.00 |
| Mar 31, 2026 | 151,728.00 |
| Dec 31, 2025 | 57,458.00 |
| Sep 30, 2025 | 65,355.00 |
| Jun 30, 2025 | 74,655.00 |
| Mar 31, 2025 | 75,818.00 |
| Dec 31, 2024 | -249,227.00 |
| Sep 30, 2024 | 123,767.00 |
| Jun 30, 2024 | 430,285.00 |
| Mar 31, 2024 | 89,141.00 |
| Dec 31, 2023 | 157,464.00 |
| Sep 30, 2023 | 168,944.00 |
| Jun 30, 2023 | 199,457.00 |
| Mar 31, 2023 | 172,821.00 |
| Dec 31, 2022 | 84,599.00 |
| Sep 30, 2022 | 260,961.00 |
| Jun 30, 2022 | 156,924.00 |
| Mar 31, 2022 | -12,870.00 |
| Dec 31, 2021 | 946,747.00 |
| Sep 30, 2021 | -3.54 Mn |
API Access
Sunshine Biopharma Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=SBFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "SBFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=SBFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();